PRESS RELEASE published on 11/03/2023 at 18:05, 2 years 6 months ago Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1
PRESS RELEASE published on 10/25/2023 at 15:00, 2 years 6 months ago Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs
PRESS RELEASE published on 10/17/2023 at 14:00, 2 years 7 months ago Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society
PRESS RELEASE published on 07/06/2023 at 14:00, 2 years 10 months ago Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases
PRESS RELEASE published on 06/05/2023 at 14:00, 2 years 11 months ago Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi
PRESS RELEASE published on 03/27/2023 at 16:04, 3 years 1 month ago Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases
Published on 05/19/2026 at 19:45, 57 minutes ago Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative
Published on 05/19/2026 at 16:47, 3 hours 55 minutes ago Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order
Published on 05/19/2026 at 15:15, 5 hours 27 minutes ago Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion
Published on 05/19/2026 at 15:00, 5 hours 42 minutes ago Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
Published on 05/19/2026 at 14:45, 5 hours 57 minutes ago Nextech3D.ai Announces Release Date for Q4 and Full Year 2026 Audited Financial Results on June 30th
Published on 05/19/2026 at 19:50, 52 minutes ago EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued
Published on 05/19/2026 at 19:40, 1 hour 2 minutes ago PRC-Saltillo Named to Forbes Accessibility 200 List
Published on 05/19/2026 at 19:05, 1 hour 37 minutes ago Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics
Published on 05/19/2026 at 18:56, 1 hour 46 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/19/2026 at 18:44, 1 hour 57 minutes ago smava GmbH publishes bond prospectus and applies for admission to trading of bonds on Nasdaq Stockholm
Published on 05/19/2026 at 18:34, 2 hours 7 minutes ago Availability of preparatory documents for the annual general meeting to be held on June 9, 2026
Published on 05/19/2026 at 17:45, 2 hours 57 minutes ago EURAZEO INVESTS IN NEXTRON SYSTEMS, A GERMAN CYBERSECURITY COMPANY SPECIALISED IN THREAT INTELLIGENCE AND CYBER FORENSICS
Published on 05/18/2026 at 22:25, 22 hours 17 minutes ago Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
Published on 05/18/2026 at 18:00, 1 day 2 hours ago Covivio Hotels - Covivio continues its expansion in hospitality in Southern Europe with a new acquisition in Torremolinos, Spain
